[{"NetIncomeLossConverted_1_Q1_USD":-40642000.0,"StockholdersEquityConverted_0_Q1_USD":725717000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-58245000.0,"CommonStockSharesOutstanding_0_Q1_shares":139884698.0,"StockholdersEquity_0_Q1_USD":725588000.0,"EarningsPerShareBasic_1_Q1_USD":-0.29,"RevenuesConverted_1_Q1_USD":38442000.0,"Assets_0_Q1_USD":1072093000.0,"CommonStockSharesConverted_0_Q1_shares":139884698.0,"Ticker":"ADPT","CIK":"1478320","name":"ADAPTIVE BIOTECHNOLOGIES CORP","OfficialName":"Adaptive Biotechnologies Corporation Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1463975665.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]